| Leuprolide Acetate Injection [14 mg/2.8 mL (1 mg/0.2 mL)] Rx only | Product name | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 2026-05-28 |
| Leuprolide Acetate Injection Rx only | Product name | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-05-25 |
| Leuprolide Acetate Injection Rx Only | Product name | Sandoz Inc | 2026-05-19 |
| Leuprolide Acetate Injection Rx only | Product name | Eugia US LLC | EUGIA Pharma Specialities Limited | 2026-05-08 |
| These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | TOLMAR Inc. | 2026-04-30 |
| These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | URONOVA PHARMACEUTICALS, INC. | 2026-04-30 |
| Leuprolide Acetate Injection Rx only | Product name | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2026-04-24 |
| Leuprolide Acetate Injection | Product name | Meitheal Pharmaceuticals Inc | 2026-04-23 |
| Leuprolide Acetate Injection (leuprolide acetate) (For Subcutaneous Injection) | Product name | Avenacy, LLC | 2026-04-13 |
| Leuprolide Acetate Injection Rx only | Product name | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-04-03 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | Product name | UBI Pharma Inc. | 2026-03-29 |
| Leuprolide Acetate Injection Rx only | Product name | Sun Pharmaceutical Industries, Inc. | Sun Pharmaceutical Industries Limited | 2026-03-27 |
| These highlights do not include all the information needed to use LUPRON DEPOT safely and effectively. See full prescribing information for LUPRON DEPOT. LUPRON DEPOT ® (leuprolide acetate for depot suspension) Initial U.S. Approval: 1989 | Product name | AbbVie Inc. | 2026-03-15 |
| Leuprolide Acetate Injection Rx only | Product name | Eugia US LLC | EUGIA Pharma Specialities Limited | 2026-03-11 |
| These highlights do not include all the information needed to use CAMCEVI ® safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Product name | Accord BioPharma, Inc. | Fareva Pau | ScinoPharm Taiwan, Ltd. | 2026-02-18 |
| These highlights do not include all the information needed to use CAMCEVI ® safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Product name | Accord BioPharma, Inc. | Fareva Pau | 2026-02-18 |
| Leuprolide Acetate Injection Rx only | Product name | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-02-09 |
| Leuprolide Acetate Injection Rx only | Product name | Zydus Lifesciences Limited | 2026-02-09 |
| These highlights do not include all the information needed to use CAMCEVI ® safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Product name | Accord BioPharma, Inc. | Fareva Pau | ScinoPharm Taiwan, Ltd. | 2026-01-21 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | Product name | PAI Holdings, LLC dba PAI Pharma | 2026-01-16 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | Product name | UBI Pharma Inc. | 2025-12-21 |
| Leuprolide Acetate Injection [14 mg/2.8 mL (1 mg/0.2 mL)] Rx only | Product name | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals of New York, LLC | Amneal Pharmaceuticals Private Limited | 2025-12-17 |
| Leuprolide Acetate Injection Rx only | Product name | VGYAAN Pharmaceuticals LLC | RK Pharma INC | 2025-11-21 |
| These highlights do not include all the information needed to use LUPRON DEPOT-PED safely and effectively. See full prescribing information for LUPRON DEPOT-PED. LUPRON DEPOT-PED ® (leuprolide acetate for depot suspension) , for intramuscular use Initial U.S. Approval: 1985 | Product name | AbbVie Inc. | 2025-11-14 |
| Leuprolide Acetate Injection Rx Only | Product name | Sandoz Inc | 2025-11-03 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | Product name | UBI Pharma Inc. | 2025-10-06 |
| These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985 | Product name | TOLMAR Inc. | 2025-09-25 |
| These highlights do not include all the information needed to use LUPRON DEPOT 3.75 mg safely and effectively. See full prescribing information for LUPRON DEPOT 3.75 mg. LUPRON DEPOT 3.75 mg (leuprolide acetate for depot suspension) for injection, for intramuscular use Initial U.S. Approval: 1985 | Product name | AbbVie Inc. | 2025-09-18 |
| These highlights do not include all the information needed to use LUPRON DEPOT 11.25 mg safely and effectively. See full prescribing information for LUPRON DEPOT 11.25 mg. LUPRON DEPOT 11.25 mg (leuprolide acetate for depot suspension) for injection, for intramuscular use Initial U.S. Approval: 1985 | Product name | AbbVie Inc. | 2025-09-10 |
| These highlights do not include all the information needed to use LUPRON DEPOT safely and effectively. See full prescribing information for LUPRON DEPOT. LUPRON DEPOT (leuprolide acetate for depot suspension) Initial U.S. Approval: 1989 | Product name | AbbVie Inc. | 2025-08-18 |
| Leuprolide Acetate Injection (leuprolide acetate) Rx only | Product name | UBI Pharma Inc. | 2025-06-30 |
| Leuprolide Acetate Injection Rx only | Product name | NorthStar RxLLC | RK Pharma INC | 2025-06-24 |
| Leuprolide Acetate Injection | Product name | Meitheal Pharmaceuticals Inc | 2025-06-16 |
| These highlights do not include all the information needed to use LUTRATE DEPOT safely and effectively. See full prescribing information for LUTRATE DEPOT. LUTRATE ® DEPOT (leuprolide acetate), for depot suspension Initial U.S. Approval: 2018 | Product name | Avyxa Pharma, LLC | 2025-06-03 |
| These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | URONOVA PHARMACEUTICALS, INC. | 2025-06-01 |
| These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | URONOVA PHARMACEUTICALS, INC. | 2025-06-01 |
| These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | URONOVA PHARMACEUTICALS, INC. | 2025-06-01 |
| Leuprolide Acetate Injection Rx only | Product name | Sandoz Inc | 2024-11-26 |
| These highlights do not include all the information needed to use LEUPROLIDE ACETATE FOR DEPOT SUSPENSION safely and effectively. See full prescribing information for LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. LEUPROLIDE ACETATE FOR DEPOT SUSPENSION. Initial U.S. Approval: 2018 | Product name | CIPLA USA INC. | GP PHARM SA | 2024-08-27 |
| These highlights do not include all the information needed to use FENSOLVI ® safely and effectively. See full prescribing information for FENSOLVI. FENSOLVI (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 1985 | Product name | TOLMAR Inc. | 2022-04-28 |
| These highlights do not include all the information needed to use CAMCEVI™ safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021 | Product name | Foresee Pharmaceuticals Co., Ltd. | Pierre Fabre Medicament Production | ScinoPharm Taiwan, Ltd. | 2021-11-15 |
| These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002 | Product name | TOLMAR Inc. | 2019-04-29 |
| LUPRON ® INJECTION (leuprolide acetate) | Product name | TAP Pharmaceutical Products Inc. | 2008-02-29 |
| Viadur ® (leuprolide acetate implant) | Product name | Bayer Pharmaceuticals Corporation | 2006-05-10 |